Positron Corporation (POSC)
USD 1.57
(-16.49%)
USD 1.57
(-16.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.36 Million USD | 49.28% |
| 2022 | -2.68 Million USD | -251.37% |
| 2021 | -763.57 Thousand USD | -1130.18% |
| 2020 | -62.07 Thousand USD | -199.13% |
| 2019 | -20.75 Thousand USD | -265.34% |
| 2018 | 12.55 Thousand USD | 0.0% |
| 2014 | -2.74 Million USD | 17.83% |
| 2013 | -3.33 Million USD | 29.31% |
| 2012 | -4.72 Million USD | -7.51% |
| 2011 | -4.39 Million USD | 69.59% |
| 2010 | -14.44 Million USD | -199.11% |
| 2009 | -4.82 Million USD | 42.01% |
| 2008 | -8.32 Million USD | -15.46% |
| 2007 | -7.21 Million USD | -89.14% |
| 2006 | -3.81 Million USD | -24.93% |
| 2005 | -3.05 Million USD | -103.2% |
| 2004 | -1.5 Million USD | -8.76% |
| 2003 | -1.38 Million USD | 48.76% |
| 2002 | -2.69 Million USD | 26.06% |
| 2001 | -3.64 Million USD | -77.03% |
| 2000 | -2.05 Million USD | -22.78% |
| 1999 | -1.67 Million USD | -691.04% |
| 1998 | -212 Thousand USD | 94.61% |
| 1997 | -3.93 Million USD | 34.62% |
| 1996 | -6.01 Million USD | -22.71% |
| 1995 | -4.9 Million USD | -13.95% |
| 1994 | -4.3 Million USD | -65.38% |
| 1993 | -2.6 Million USD | -116.67% |
| 1992 | -1.2 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -488.46 Thousand USD | -30.45% |
| 2023 Q4 | -374.44 Thousand USD | 21.3% |
| 2023 Q1 | -231.59 Thousand USD | -178.76% |
| 2023 Q3 | -475.78 Thousand USD | -70.57% |
| 2023 FY | -1.36 Million USD | 49.28% |
| 2023 Q2 | -278.94 Thousand USD | -20.45% |
| 2022 Q3 | -525.85 Thousand USD | -204.96% |
| 2022 Q1 | -1.35 Million USD | -2648.67% |
| 2022 FY | -2.68 Million USD | -251.37% |
| 2022 Q2 | -172.43 Thousand USD | 87.24% |
| 2022 Q4 | -83.08 Thousand USD | 84.2% |
| 2021 Q4 | 53.03 Thousand USD | 123.69% |
| 2021 Q3 | -223.82 Thousand USD | 32.37% |
| 2021 Q2 | -330.95 Thousand USD | -26.4% |
| 2021 Q1 | -261.83 Thousand USD | 0.0% |
| 2021 FY | -763.57 Thousand USD | -1130.18% |
| 2020 FY | -62.07 Thousand USD | -199.13% |
| 2020 Q2 | -24.78 Thousand USD | 0.0% |
| 2019 FY | -20.75 Thousand USD | -265.34% |
| 2018 FY | 12.55 Thousand USD | 0.0% |
| 2015 Q1 | -531 Thousand USD | 17.55% |
| 2015 Q3 | -170 Thousand USD | 23.77% |
| 2015 Q2 | -223 Thousand USD | 58.0% |
| 2014 Q2 | -707 Thousand USD | -3.21% |
| 2014 FY | -2.74 Million USD | 17.83% |
| 2014 Q4 | -644 Thousand USD | 8.91% |
| 2014 Q3 | -707 Thousand USD | 0.0% |
| 2014 Q1 | -685 Thousand USD | 41.75% |
| 2013 Q1 | -769 Thousand USD | 21.21% |
| 2013 Q2 | -658 Thousand USD | 14.43% |
| 2013 FY | -3.33 Million USD | 29.31% |
| 2013 Q3 | -736 Thousand USD | -11.85% |
| 2013 Q4 | -1.17 Million USD | -59.78% |
| 2012 Q3 | -803 Thousand USD | 29.62% |
| 2012 FY | -4.72 Million USD | -7.51% |
| 2012 Q2 | -1.14 Million USD | 36.68% |
| 2012 Q4 | -976 Thousand USD | -21.54% |
| 2012 Q1 | -1.8 Million USD | -81.65% |
| 2011 Q3 | -1.1 Million USD | 29.71% |
| 2011 FY | -4.39 Million USD | 69.59% |
| 2011 Q4 | -992 Thousand USD | 9.82% |
| 2011 Q2 | -1.56 Million USD | -112.93% |
| 2011 Q1 | -735 Thousand USD | 53.01% |
| 2010 Q1 | -3.14 Million USD | -39.14% |
| 2010 FY | -14.44 Million USD | -199.11% |
| 2010 Q3 | -2.63 Million USD | 62.9% |
| 2010 Q4 | -1.56 Million USD | 40.62% |
| 2010 Q2 | -7.1 Million USD | -125.68% |
| 2009 FY | -4.82 Million USD | 42.01% |
| 2009 Q3 | -1.19 Million USD | -41.25% |
| 2009 Q2 | -846 Thousand USD | -60.53% |
| 2009 Q1 | -527 Thousand USD | 89.87% |
| 2009 Q4 | -2.26 Million USD | -89.21% |
| 2008 Q2 | -739 Thousand USD | 50.27% |
| 2008 Q3 | -899 Thousand USD | -21.65% |
| 2008 Q4 | -5.2 Million USD | -478.75% |
| 2008 Q1 | -1.48 Million USD | 61.15% |
| 2008 FY | -8.32 Million USD | -15.46% |
| 2007 FY | -7.21 Million USD | -89.14% |
| 2007 Q4 | -3.82 Million USD | -208.47% |
| 2007 Q1 | -1.05 Million USD | 43.13% |
| 2007 Q2 | -1.09 Million USD | -3.51% |
| 2007 Q3 | -1.24 Million USD | -13.55% |
| 2006 Q2 | -850 Thousand USD | -0.59% |
| 2006 FY | -3.81 Million USD | -24.93% |
| 2006 Q1 | -845 Thousand USD | 32.18% |
| 2006 Q3 | -262 Thousand USD | 69.18% |
| 2006 Q4 | -1.85 Million USD | -608.02% |
| 2005 FY | -3.05 Million USD | -103.2% |
| 2005 Q4 | -1.24 Million USD | -118.21% |
| 2005 Q2 | -677 Thousand USD | -21.33% |
| 2005 Q3 | -571 Thousand USD | 15.66% |
| 2005 Q1 | -558 Thousand USD | -12.96% |
| 2004 Q1 | -246 Thousand USD | 38.35% |
| 2004 Q3 | -141 Thousand USD | 77.29% |
| 2004 Q4 | -494 Thousand USD | -250.35% |
| 2004 FY | -1.5 Million USD | -8.76% |
| 2004 Q2 | -621 Thousand USD | -152.44% |
| 2003 Q2 | -493 Thousand USD | -870.31% |
| 2003 Q4 | -399 Thousand USD | 27.85% |
| 2003 FY | -1.38 Million USD | 48.76% |
| 2003 Q3 | -553 Thousand USD | -12.17% |
| 2003 Q1 | 64 Thousand USD | 108.52% |
| 2002 Q4 | -751 Thousand USD | -19.4% |
| 2002 Q1 | -456 Thousand USD | 74.78% |
| 2002 Q2 | -859 Thousand USD | -88.38% |
| 2002 Q3 | -629 Thousand USD | 26.78% |
| 2002 FY | -2.69 Million USD | 26.06% |
| 2001 Q1 | -691 Thousand USD | 27.19% |
| 2001 Q4 | -1.8 Million USD | -234.81% |
| 2001 Q2 | -606 Thousand USD | 12.3% |
| 2001 FY | -3.64 Million USD | -77.03% |
| 2001 Q3 | -540 Thousand USD | 10.89% |
| 2000 Q3 | -492 Thousand USD | -30.85% |
| 2000 FY | -2.05 Million USD | -22.78% |
| 2000 Q2 | -376 Thousand USD | -55.37% |
| 2000 Q1 | -242 Thousand USD | 0.0% |
| 2000 Q4 | -949 Thousand USD | -92.89% |
| 1999 FY | -1.67 Million USD | -691.04% |
| 1998 FY | -212 Thousand USD | 94.61% |
| 1997 Q1 | -1.2 Million USD | 64.55% |
| 1997 FY | -3.93 Million USD | 34.62% |
| 1996 Q3 | -900 Thousand USD | 35.71% |
| 1996 Q4 | -3.38 Million USD | -276.11% |
| 1996 FY | -6.01 Million USD | -22.71% |
| 1996 Q2 | -1.4 Million USD | 36.36% |
| 1996 Q1 | -2.2 Million USD | -69.23% |
| 1995 Q2 | -600 Thousand USD | 60.0% |
| 1995 Q1 | -1.5 Million USD | -36.36% |
| 1995 Q4 | -1.3 Million USD | 13.33% |
| 1995 Q3 | -1.5 Million USD | -150.0% |
| 1995 FY | -4.9 Million USD | -13.95% |
| 1994 Q2 | -1.2 Million USD | -20.0% |
| 1994 Q1 | -1 Million USD | 87.5% |
| 1994 FY | -4.3 Million USD | -65.38% |
| 1994 Q3 | -1.1 Million USD | 8.33% |
| 1994 Q4 | -1.1 Million USD | 0.0% |
| 1993 Q3 | 1.9 Million USD | 5.56% |
| 1993 Q2 | 1.8 Million USD | 0.0% |
| 1993 FY | -2.6 Million USD | -116.67% |
| 1993 Q4 | -8 Million USD | -521.05% |
| 1993 Q1 | 1.8 Million USD | 134.62% |
| 1992 Q3 | 1.7 Million USD | 6.25% |
| 1992 Q4 | -5.2 Million USD | -405.88% |
| 1992 FY | -1.2 Million USD | 0.0% |
| 1992 Q1 | 1.6 Million USD | 0.0% |
| 1992 Q2 | 1.6 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -396.099% |
| IR-Med Inc. | -4.91 Million USD | 72.292% |
| Polarean Imaging plc | -12.55 Million USD | 89.163% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 410.546% |
| Avitar, Inc. | 2.73 Million USD | 149.793% |
| AVITA Medical, Inc. | -40.4 Million USD | 96.632% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -93.563% |
| Össur hf. | 87.46 Million USD | 101.556% |
| Zecotek Photonics Inc. | -3.65 Million USD | 62.788% |
| QHSLab, Inc. | -240.15 Thousand USD | -466.606% |
| Wellstar International, Inc. | -1.79 Million USD | 24.179% |
| Össur hf. | 87.46 Million USD | 101.556% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 165.389% |
| Escalon Medical Corp. | -104.47 Thousand USD | -1202.452% |
| Aurora Spine Corporation | -446.19 Thousand USD | -204.967% |
| BrainsWay Ltd. | -4.92 Million USD | 72.382% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 85.615% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 589.484% |
| Vivos Inc. | -2.79 Million USD | 51.283% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.736% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -468.956% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 23.193% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -259.126% |
| Nanomix Corporation | -8.43 Million USD | 83.872% |
| Theraclion SA | -3.48 Million USD | 60.908% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -92.461% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 34.102% |
| Lombard Medical, Inc. | -29.33 Million USD | 95.361% |
| ALR Technologies Inc. | -2.94 Million USD | 53.815% |
| Stratec SE | 25.26 Million USD | 105.385% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 3485.708% |
| Heart Tronics, Inc. | 14.46 Million USD | 109.41% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -1029.01% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 93.436% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -151.991% |
| VMS Rehab Systems, Inc. | -68.66 USD | -1981767.172% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 60.638% |
| Ingen Technologies, Inc. | -1.61 Million USD | 15.672% |
| Odyssey Group International, Inc. | 14.26 Million USD | 109.542% |
| United American Healthcare Corporation | -67 Thousand USD | -1930.97% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -233.943% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -114.397% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -126.218% |
| Urologix, Inc. | -6.93 Million USD | 80.364% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -7.711% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 78.28% |
| SS Innovations International, Inc. | -20.66 Million USD | 93.416% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -491.011% |
| Smith & Nephew plc | 425 Million USD | 100.32% |
| NIOX Group Plc | 4.6 Million USD | 129.582% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 454.528% |
| Broncus Holding Corporation | -33.22 Million USD | 95.904% |
| Brain Scientific Inc. | -9.6 Million USD | 85.838% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 85.681% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -2141.8% |